186 related articles for article (PubMed ID: 20427388)
1. COX-2 expression in adenoma: an imperfect marker for chemoprevention.
Chan AT
Gut; 2010 May; 59(5):568-9. PubMed ID: 20427388
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention.
Hubner RA; Muir KR; Liu JF; Logan RF; Grainge MJ; Houlston RS;
Clin Cancer Res; 2008 Apr; 14(8):2303-9. PubMed ID: 18413818
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
5. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
Doherty GA; Murray FE
Expert Opin Ther Targets; 2009 Feb; 13(2):209-18. PubMed ID: 19236238
[TBL] [Abstract][Full Text] [Related]
7. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
[TBL] [Abstract][Full Text] [Related]
8. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Chevalier TL; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
[TBL] [Abstract][Full Text] [Related]
9. Is aspirin for colorectal cancer prevention on the prime time yet?
Sung JJ
Gut; 2014 Nov; 63(11):1691-2. PubMed ID: 24821617
[No Abstract] [Full Text] [Related]
10. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
Kleibeuker JH; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
[TBL] [Abstract][Full Text] [Related]
11. DFMO: targeted risk reduction therapy for colorectal neoplasia.
Laukaitis CM; Gerner EW
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):495-506. PubMed ID: 22122766
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
13. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
[TBL] [Abstract][Full Text] [Related]
14. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial.
Ishikawa H; Mutoh M; Suzuki S; Tokudome S; Saida Y; Abe T; Okamura S; Tajika M; Joh T; Tanaka S; Kudo SE; Matsuda T; Iimuro M; Yukawa T; Takayama T; Sato Y; Lee K; Kitamura S; Mizuno M; Sano Y; Gondo N; Sugimoto K; Kusunoki M; Goto C; Matsuura N; Sakai T; Wakabayashi K
Gut; 2014 Nov; 63(11):1755-9. PubMed ID: 24488498
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
Elder DJ; Halton DE; Crew TE; Paraskeva C
Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
[TBL] [Abstract][Full Text] [Related]
16. COX-2 inhibitors for colorectal cancer.
Elder DJ; Paraskeva C
Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
[No Abstract] [Full Text] [Related]
17. Aspirin: still learning about the wonder drug.
Hawk ET; Viner JL
Gut; 2003 Nov; 52(11):1535-6. PubMed ID: 14570718
[No Abstract] [Full Text] [Related]
18. The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.
Rahme E; Barkun AN; Toubouti Y; Bardou M
Gastroenterology; 2003 Aug; 125(2):404-12. PubMed ID: 12891542
[TBL] [Abstract][Full Text] [Related]
19. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials.
Gao F; Liao C; Liu L; Tan A; Cao Y; Mo Z
Colorectal Dis; 2009 Nov; 11(9):893-901. PubMed ID: 19055515
[TBL] [Abstract][Full Text] [Related]
20. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
